Marshall Wace, LLP Vapotherm Inc Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.44 - $13.52 $70,198 - $659,086	48,749 Added 22.01%	270,253 $424,000
Q2 2022 Aug 15, 2022	BUY	$2.52 - $14.42 $558,190 - $3.19 Million	221,504 New	221,504 $561,000
Q1 2022 May 16, 2022	SELL	$12.69 - $20.72 $255,107 - $416,534	-20,103 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.7 - $23.71 $840,067 - $1.01 Million	-42,643 Reduced 67.96%	20,103 $416,000
Q3 2021 Nov 15, 2021	BUY	$21.32 - $29.36 $634,248 - $873,430	29,749 Added 90.16%	62,746 $1.4 Million
Q2 2021 Aug 13, 2021	BUY	$17.01 - $24.14 $322,356 - $457,477	18,951 Added 134.92%	32,997 $780,000
Q1 2021 May 17, 2021	BUY	$21.8 - $36.52 $306,202 - $512,959	14,046 New	14,046 $337,000
Q2 2020 Aug 13, 2020	SELL	$16.0 - $40.99 $593,584 - $1.52 Million	-37,099 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.79 - $19.91 $289,001 - $738,641	37,099 New	37,099 $699,000

1.35M

Ticker VAPO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,697,200
Market Cap $57.9M
Description
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.